Optical Radiation Corp.
This article was originally published in The Gray Sheet
Executive SummaryAnnounces that Akorn Inc. has opted to terminate its June 30 letter of intent to acquire Optical Radiation's $15 mil. intraocular lens business. Akorn had offered 5.25 mil. shares of its stock for the IOL business ('The Gray Sheet" July 4, p. 9); the reason for termination of the deal was not disclosed. Asuza, California-based Optical Radiation "has begun discussion with other interested parties" and expects to complete another deal before the company merges in October with Benson Eyecare Corp
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.